FDA staff leaving for industry jobs given “behind the scenes” lobbying advice
Practice highlights “critical loophole” in the revolving door between the FDA and industry The US Food and Drug Administration (FDA) tells staff leaving for industry jobs that, despite restrictions on post-employment lobbying, they are still permitted to influence the agency, reveals an investigation by The BMJ today. Internal emails, obtained under a ...